Safety and Efficacy of Low-dose hEparinization in Cerebral Angiography sTudy

PHASE4CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

June 1, 2021

Study Completion Date

January 1, 2022

Conditions
Cerebral AngiographyHeparinization
Interventions
DRUG

Heparin

As soon as the sheath was inserted, three different doses of heparin were administered according to the patients group assignment. In the conventional systemic heparinization (Regular-dose) group (The drug is Heparin Sodium Injection 2ml:12500 Units per bottle), systemic heparin was administered by intravenous injection at a dose of 83 Units/Kg. Patients in both the regular dose (83 units/kg) and low dose (42 units/kg) groups were given heparin intravenously once before the procedure of cerebral angiography, and no further heparin infusion was given during the angiography procedure. If the duration of the imaging procedure exceeded 1 hour, an additional 1/2 amount of the first dose of heparin was given.

DRUG

Heparin Sodium Injection

In the micro-dose systemic heparinization (Micro-dose) group (the drug is Heparin Sodium Injection 2ml:12500 Units per bottle), systemic heparin was administered by intravenous injection at a dose of 42 Units/Kg. Patients in both the regular dose (83 units/kg) and low dose (42 units/kg) groups were given heparin intravenously once before the procedure of cerebral angiography, and no further heparin infusion was given during the angiography procedure. If the duration of the imaging procedure exceeded 1 hour, an additional 1/2 amount of the first dose of heparin was given.

OTHER

No heparinization

No additional heparin was administered via the sheath or arterial route in the no heparinization group.

Trial Locations (2)

100053

Xuanwu Hospital, Capital Medical University., Beijing

Unknown

Xuanwu Hospital, Capital Medical University, Beijing

All Listed Sponsors
lead

Xuanwu Hospital, Beijing

OTHER

NCT06365398 - Safety and Efficacy of Low-dose hEparinization in Cerebral Angiography sTudy | Biotech Hunter | Biotech Hunter